Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework

Abstract

The translation of personal genomics to precision medicine depends on the accurate interpretation of the multitude of genetic variants observed for each individual. However, even when genetic variants are predicted to modify a protein, their functional implications may be unclear. Many diseases are caused by genetic variants affecting important protein features, such as enzyme active sites or interaction interfaces. The scientific community has catalogued millions of genetic variants in genomic databases and thousands of protein structures in the Protein Data Bank. Mapping mutations onto three-dimensional (3D) structures enables atomic-level analyses of protein positions that may be important for the stability or formation of interactions; these may explain the effect of mutations and in some cases even open a path for targeted drug development. To accelerate progress in the integration of these data types, we held a two-day Gene Variation to 3D (GVto3D) workshop to report on the latest advances and to discuss unmet needs. The overarching goal of the workshop was to address the question: what can be done together as a community to advance the integration of genetic variants and 3D protein structures that could not be done by a single investigator or laboratory? Here we describe the workshop outcomes, review the state of the field, and propose the development of a framework with which to promote progress in this arena. The framework will include a set of standard formats, common ontologies, a common application programming interface to enable interoperation of the resources, and a Tool Registry to make it easy to find and apply the tools to specific analysis problems. Interoperability will enable integration of diverse data sources and tools and collaborative development of variant effect prediction methods.Electronic supplementary materialThe online version of this article (doi:10.1186/s13073-017-0509-y) contains supplementary material, which is available to authorized users.

Genomic Analysis in the Age of Human Genome Sequencing

“…However, predicting whether an amino acid change actually changes protein structure and function is extremely difficult. Diverse computational prediction models use both protein structure and conservation data (Glusman et al, 2017), but sparsity of experimental validation data remains a challenge (Raraigh et al, 2018). Splicing changes may dramatically alter protein structure or introduce a premature stop codon.…”

Calculating the Effects of Autism Risk Gene Variants on Dysfunction of Biological Processes Identifies Clinically-Useful Information

“…Only 0.14% of the variants that VEP predicted to be highly likely of damaging the protein product based on the location in the coding region of the gene were predicted to be damaging by all of the other nine prediction algorithms evaluated. Fortunately, as the field of in silico variant prediction continues to develop novel methods, focused on advances like mapping variants to three-dimensional protein structures( 70 ), predictions should become more accurate and variant prioritization more efficient.…”

Towards predictive biophysical and mechanistic models for disease-causing protein variants

“…We expect that unbiased functional data from DMS experiments will be extremely useful in assessing and parameterizing prediction methods for a much wider set of amino acid changes. An important problem to tackle in the future is to map genetic variants on to accurate structural models for the entire human proteome [71], and to develop prediction methods that are robust towards structural noise in homology models. Finally, an important open question is how the different prediction methods are best combined, and how they can both provide accurate predictions of pathogenicity and aid in developing mechanistic hypotheses for the origin of disease.…”